Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GTHP |
---|---|---|
10:13 ET | 5000 | 0.16 |
10:27 ET | 400 | 0.185 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Guided Therapeutics Inc | 11.3M | -4.3x | --- |
Bionoid Pharma Inc | 10.8M | 0.2x | --- |
ALR Technologies Inc | 9.0M | -1.0x | --- |
Autonomix Medical Inc | 7.2M | -0.4x | --- |
Kelyniam Global Inc | 6.4M | -8.3x | --- |
Caduceus Software Systems Corp | 5.6M | -17.9x | --- |
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $11.3M |
---|---|
Revenue (TTM) | $38.0K |
Shares Outstanding | 61.0M |
Guided Therapeutics Inc does not pay a dividend. | |
Beta | 0.49 |
EPS | $-0.04 |
Book Value | $-0.07 |
P/E Ratio | -4.3x |
Price/Sales (TTM) | 297.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -4,957.90% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.